Advanced ovarian cancer is the most lethal gynecological cancer, with a high rate of chemoresistance and relapse. Photodynamic therapy offers new prospects for ovarian cancer treatment, but current photosensitizers lack tumor specificity, resulting in low efficacy and significant side-effects. In the present work, the clinically approved photosensitizer verteporfin was encapsulated within nanostructured lipid carriers (NLC) for targeted photodynamic therapy of ovarian cancer. Cellular uptake and phototoxicity of free verteporfin and NLC-verteporfin were studied in vitro in human ovarian cancer cell lines cultured in 2D and 3D-spheroids, and biodistribution and photodynamic therapy were evaluated in vivo in mice. Both molecules were internalized in ovarian cancer cells and strongly inhibited tumor cells viability when exposed to laser light only. In vivo biodistribution and pharmacokinetic studies evidenced a long circulation time of NLC associated with efficient tumor uptake. Administration of 2 mg·kg⁻¹ free verteporfin induced severe phototoxic adverse effects leading to the death of 5 out of 8 mice. In contrast, laser light exposure of tumors after intravenous administration of NLC-verteporfin (8 mg·kg⁻¹) significantly inhibited tumor growth without visible toxicity. NLC-verteporfin thus led to efficient verteporfin vectorization to the tumor site and protection from side-effects, providing promising therapeutic prospects for photodynamic therapy of cancer.

The development of new energy storage technologies is central to solving the challenges facing the widespread use of renewable energies. An option is the reduction of carbon dioxide (CO₂) into carbon-based products which can be achieved within an electrochemical cell. Future developments of such processes depend on the availability of cheap and selective catalysts at the electrode. Here we show that a unique well-characterized active electrode material can be simply prepared via electrodeposition from a molecular copper complex precursor. The best performances, namely activity (150 mV onset overpotential and 1 mA cm⁻² current density at 540 mV overpotential), selectivity (90% faradaic yield) and stability for electrocatalytic reduction of CO₂ into formic acid in DMF/H₂O (97 : 3 v/v) have been obtained with the [Cu(cyclam)](ClO₄)₂ complex (cyclam = 1,4,8,11-tetraazacyclotetradecane) as the precursor. Remarkably the organic ligand of the Cu precursor remains part of the composite material and the electrocatalytic activity is greatly dependent on the nature of that organic component.